(Q67655854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690655

30 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

30 October 2022

author name string

J. C. Kirchheimer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690655

30 October 2022

H. Kölbl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690655

30 October 2022

G. Tatra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690655

30 October 2022

B. R. Binder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1690655

30 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1690655

30 October 2022

publication date

1 February 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2362.1990.tb01795.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1990.tb01795.x/fullpdf

30 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

European Journal of Clinical Investigation

30 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

79-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

Plasminogen activation and regulation of pericellular proteolysis

16 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Immunological characterization of plasminogen activator activities in human tissues and body fluids

30 October 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

30 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines

30 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen

30 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator

30 October 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas

30 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer

30 October 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas

30 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

30 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

30 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

The role of the fibrinolytic system in deep vein thrombosis

30 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

30 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor

30 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions

30 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation

30 October 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma

30 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasminogen: Purification from Human Plasma by Affinity Chromatography

30 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2.

30 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Urokinase antigen in plasma: age and sex dependent variations

30 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Sandwich ELISA for t-PA antigen employing a monoclonal antibody

30 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.

30 October 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Plasminogen activator response after DDAVP: a clinico-pharmacological study

30 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

Increased plasminogen activator inhibition levels in malignancy

30 October 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2362.1990.TB01795.X

30 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690655%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference